GlassScriptPhysician profile
Paul L Asdourian
NPI 1962446765
$44,966.08
in general payments reported to CMS, 2019-2025
12 companies · $987 in 2025
The $987 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $11K · 2021: $6,265 · 2022: $7,883 · 2023: $2,412 · 2024: $819 · 2025: $987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1,609 · Food and Beverage: $1,446 · Travel and Lodging: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,608.53 |
| Food and Beverage | $1,446.07 |
| Travel and Lodging | $1,163.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $31,123.29 | 2019-2024 | Novel |
| Globus Medical, INC. | $12,455.96 | 2019-2023 | Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $277.22 | 2019-2025 | Serrato, N/A |
| Vb Spine LLC | $275.84 | 2025 | Q Guidance System |
| Arthrex, INC. | $219.00 | 2025 | |
| Circinus Medical Technology LLC | $200.03 | 2025 | Bolt Navigation |
| Supreme Orthopedic Systems, LLC | $149.99 | 2025 | |
| Medtronic, INC. | $146.62 | 2022 | |
| Kci USA, INC. | $102.91 | 2023 | V.A.C. Veraflo, Prevena |
| Smith+Nephew, INC. | $15.22 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,183,788.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Asdourian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.